Published in: Nature Reviews Molecular Cell Biology vol. 6, no. 5, pp. 360-361 (May, 2005);
doi:10.1038/nrm1653
http://www.nature.com/cgi-taf/DynaPage.taf?file=/nrm/journal/v6/n5/full/nrm1653_fs.html


"TUMORIGENESIS: Micromanager".

Helen Dell

Nature Reviews Cancer

MicroRNAs (miRNAs) are now recognized to be key regulators of development and cell differentiation. Unsurprisingly, therefore, evidence is emerging that miRNAs can be mutated or abnormally expressed in human cancers. Steven M. Johnson et al. now provide a link between certain miRNAs and the notorious RAS oncogenic signalling pathway, suggesting a mechanism by which these miRNAs might regulate tumorigenesis.

Animal miRNAs are proposed to exert their regulatory effects by binding to complementary sequences in the 3' untranslated regions (UTRs) of their target mRNA, thereby controlling translation. One of the first miRNAs to be discovered was let-7 in the worm Caenorhabditis elegans, and there are now four let-7 relatives known in these creatures. let-7 controls cell fate in hypodermal seam cells, which are a type of epithelial cell, but the functions of the other family members are unknown. Johnson et al. searched the C. elegans genome for potential target genes, looking for sites complementary to a consensus let-7 family sequence in the 3' UTRs of genes. The highest-scoring candidate was let-60, the C. elegans homologue of human RAS.

The authors found that let-7 and let-60 were both expressed in hypodermal seam cells, but in a reciprocal manner, so that during developmental stages when let-7 was high, let-60 was low, and vice versa. Moreover, the let-60 3' UTR was sufficient to downregulate a reporter gene at the developmental stage when let-60 expression normally drops off. Notably, in worms with let-7 loss-of-function mutations, there was no decline in reporter-gene expression. All of which indicates that the let-60 mRNA is a functional target of let-7 in worms.

Moving into humans, Johnson et al. found several potential let-7 complementary sites in the 3' UTRs of the three RAS genes. Transfecting HepG2 cells with a let-7 miRNA reduced the expression of RAS by approx70%. Moreover, the 3' UTRs of NRAS and KRAS repressed the expression of a luciferase reporter in cells that have endogenous let-7 (HeLa cells). Co-transfection of an antisense inhibitor of let-7 relieved this repression.

Several human homologues of let-7 reside in genomic regions that are deleted in cancer, and Johnson et al. theorized that the loss of regulation by let-7 miRNA could cause overexpression of RAS and contribute to tumorigenesis. They analysed levels of let-7 in a range of cancers from 21 patients. In lung cancers, let-7 was reduced by an average of half, compared with normal adjacent tissue, and northern and western analyses revealed the reciprocal correlation between expression of let-7 miRNA and RAS protein. However, the amount of RAS protein did not seem to reflect the amount of NRAS mRNA, indicating that expression of human RAS protein is regulated significantly at the level of translation — consistent with a control mechanism in which the miRNA binds to the 3' UTR. The authors concluded that let-7 is strongly implicated as a tumour suppressor in lung tissue.

References and links:

ORIGINAL RESEARCH PAPER:

Johnson, S. M. et al. "RAS is regulated by the let-7 microRNA family". Cell 120, 635-647 (2005).

FURTHER READING:

Downward, J. "Targeting RAS signalling pathways in cancer therapy". Nature Rev. Cancer 3, 11-22 (2003)

He, L. & Hannon, G. J. "MicroRNAs: small RNAs with a big role in gene regulation". Nature Rev. Genet. 5, 522-531 (2004)

WEB SITE:
Frank Slack's lab
http://www.yale.edu/slack/


Return to: "Sense and Antisense during RNA initiation of the DNA Transcription Bubble".
 

Additional References:

Links to RNA and Biological Causality:

Further Topics in:  Euchromatin,  active DNA, and  RNA  ribo-regulators:

Links to Euchromatin Activator RNA Reviews:
Links to Euchromatin Activator RNA Research:
Links to Ultrastructural Probes of DNase I-Sensitive Sites:
Links to RNA as a Therapeutic Agent:
Links to Hodgkin Lymphoma Immuno-Pathology:
Links to Activated T-Lymphocyte Immunotherapy:
Links to Medical Systems Biology:
Links to Selective Gene Transcription:
Links to RNA-Induced Epigenetics:
Links to RNA-Induced Embryogenesis:
Links to RNA and Biological Causality:
Links to Reprogramming and Neoplasia:

A Brief History of Activator RNA:

"Ultrastructural Probes of Active DNA Sites, and the RNA Activators of DNA". (PowerPoint Presentation).




Top of Page - Euchromatin Network - Current Research - Forums - Other Sites - Future Events -


For Further Information and Feedback:
E-mail: frenster@euchromatin.net
Phone:  +1 650 367 6483
Fax:  +1 650 364 1773


euchromatin: "the most active portion of the genome within the cell nucleus".